Salem Investment Counselors Inc Vertex Pharmaceuticals Inc Transaction History

Salem Investment Counselors Inc

$3.24 Billion
Q3 2024

A detailed history of Salem Investment Counselors Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Salem Investment Counselors Inc holds 259 shares of VRTX stock, worth $116,645. This represents 0.0% of its overall portfolio holdings.

Number of Shares

259

Previous 259 -0.0%

Holding current value

$116,645

Previous $121,000 0.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	BUY	$392.81 - $485.53 $392 - $485	1 Added 0.39%	259 $121,000
Q4 2023 Jan 16, 2024	SELL	$343.0 - $410.68 $686 - $821	-2 Reduced 0.77%	258 $104,000
Q3 2023 Oct 04, 2023	BUY	$338.18 - $362.46 $676 - $724	2 Added 0.78%	260 $90,000
Q1 2023 May 11, 2023	BUY	$283.23 - $323.1 $16,427 - $18,739	58 Added 29.0%	258 $81,000
Q3 2022 Nov 09, 2022	BUY	$273.83 - $305.53 $54,766 - $61,105	200 New	200 $58,000
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $412,062 - $485,665	-1,861 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$177.01 - $223.45 $3,894 - $4,915	22 Added 1.2%	1,861 $409,000
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $362 - $405	-2 Reduced 0.11%	1,839 $334,000
Q2 2021 Aug 17, 2021	BUY	$187.49 - $221.1 $344,794 - $406,602	1,839 Added 91950.0%	1,841 $371,000
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $3,519 - $4,102	-17 Reduced 89.47%	2 $0
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $3,933 - $5,245	19 New	19 $4,000
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $34,742 - $39,101	-209 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$164.61 - $190.37 $278,190 - $321,725	-1,690 Reduced 88.99%	209 $38,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $818 - $973	5 Added 0.26%	1,899 $366,000
Q4 2018 Feb 15, 2019	SELL	$151.91 - $192.21 $759 - $961	-5 Reduced 0.26%	1,894 $314,000
Q3 2018 Nov 14, 2018	SELL	$167.73 - $192.74 $39,416 - $45,293	-235 Reduced 11.01%	1,899 $366,000
Q4 2017 Feb 16, 2018	BUY	$137.28 - $155.55 $6,864 - $7,777	50 Added 2.4%	2,134 $320,000
Q3 2017 Nov 16, 2017	BUY	$148.13 - $162.24 $308,702 - $338,108	2,084	2,084 $316,000

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.

Account

Salem Investment Counselors Inc Vertex Pharmaceuticals Inc Transaction History